HC Wainwright Has Optimistic View of electroCore Q2 Earnings

electroCore, Inc. (NASDAQ:ECOR) – Equities research analysts at HC Wainwright upped their Q2 2025 earnings per share estimates for shares of electroCore in a research report issued on Wednesday, December 18th. HC Wainwright analyst S. Ramakanth now anticipates that the company will post earnings per share of ($0.17) for the quarter, up from their prior estimate of ($0.19). HC Wainwright has a “Buy” rating and a $25.00 price objective on the stock. The consensus estimate for electroCore’s current full-year earnings is ($1.49) per share. HC Wainwright also issued estimates for electroCore’s Q3 2025 earnings at ($0.14) EPS, Q4 2025 earnings at ($0.03) EPS and FY2025 earnings at ($0.60) EPS.

electroCore Stock Up 5.2 %

Shares of ECOR stock opened at $15.27 on Friday. The stock has a 50-day simple moving average of $11.66 and a 200 day simple moving average of $8.18. The stock has a market capitalization of $100.09 million, a P/E ratio of -8.34 and a beta of 0.57. electroCore has a fifty-two week low of $5.25 and a fifty-two week high of $17.84.

Hedge Funds Weigh In On electroCore

Several large investors have recently made changes to their positions in the business. International Assets Investment Management LLC lifted its stake in electroCore by 689.1% during the third quarter. International Assets Investment Management LLC now owns 535,146 shares of the company’s stock valued at $3,864,000 after purchasing an additional 467,326 shares during the last quarter. HighTower Advisors LLC acquired a new stake in shares of electroCore during the 3rd quarter valued at $255,000. Geode Capital Management LLC boosted its stake in shares of electroCore by 10.3% during the 3rd quarter. Geode Capital Management LLC now owns 63,485 shares of the company’s stock worth $458,000 after acquiring an additional 5,951 shares in the last quarter. Finally, Renaissance Technologies LLC grew its holdings in shares of electroCore by 3.4% in the 2nd quarter. Renaissance Technologies LLC now owns 68,786 shares of the company’s stock worth $442,000 after acquiring an additional 2,270 shares during the last quarter. Institutional investors own 26.74% of the company’s stock.

About electroCore

electroCore, Inc, a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania.